TBPH icon

Theravance Biopharma
TBPH

Upgrade to unlock
Buy
Hold
Sell

2 Wall Street Analysts provided 1 year price targets over the past 3 months

Low target
Avg. target
$34
84% upside
High target

2 analyst ratings

positive
0  neutral
0%
negative
Analyst & Firm Rating Price Target Upside
Downside 		Date
BTIG
BTIG
Julian Harrison
67% 1-yr TBPH win rate
3 Feb ‘26 27 days ago
Oppenheimer
Oppenheimer
Trevor Allred
0% 1-yr TBPH win rate
3 Dec ‘25 2 months ago